NASDAQ:LPCN
Lipocine Inc. Stock News
$5.20
+0.0712 (+1.39%)
At Close: Mar 28, 2024
Lipocine to Present at the H.C. Wainwright Annual NASH Investor Conference
07:00pm, Monday, 23'rd Oct 2023
SALT LAKE CITY , Oct. 23, 2023 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company focused on treating Central Nervous System (CNS) disorders, today announced that it will presen
Why Is Lipocine (LPCN) Stock Up 32% Today?
08:40am, Thursday, 27'th Jul 2023
Lipocine (NASDAQ: LPCN ) stock is rising higher on Thursday after the company released positive results from a Phase 2 clinical trial. That trail covers the use of LPCN 1148 as a treatment for patien
Lipocine to Present LPCN 1148 and LPCN 1144 at the EASL Congress 2023
08:00am, Wednesday, 07'th Jun 2023
Phase 2 proof-of-concept study of LPCN 1148 in male cirrhotic patients with sarcopenia is fully enrolled with topline 24-week results expected mid-2023 SALT LAKE CITY , June 7, 2023 /PRNewswire/ -- Li
Lipocine to Present at Biotech Showcase
08:00am, Thursday, 05'th Jan 2023
Company Management Will Also Host Meetings at LifeSci Partners Corporate Access Event SALT LAKE CITY , Jan. 5, 2023 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company focused on
Lipocine to Present at Ladenburg Thalmann 2022 Healthcare Conference
04:10pm, Thursday, 22'nd Sep 2022
SALT LAKE CITY , Sept. 22, 2022 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company focused on leveraging its proprietary Lip'ral platform to augment therapeutics through effecti
4 Stocks Under $3 Insiders Are Aggressively Buying
12:10pm, Tuesday, 17'th May 2022 Benzinga
US crude oil futures traded slightly lower this morning on Tuesday. Investors, meanwhile, focused on some notable insider trades.
When insiders purchase or sell shares, it indicates their confidence o
7 Undervalued Penny Stocks With Major Upside
07:34pm, Tuesday, 29'th Mar 2022
Each of these penny stocks has proven momentum throughout 2022 and major upside on top of the returns through the the first quarter. The post 7 Undervalued Penny Stocks With Major Upside appeared firs
The Daily Biotech Pulse: Sanofi-IGM Ink Antibody Drug Collaboration; NeoGenomics Sinks On CEO Departure, Q1 Warning; Decision Day For Akebia
11:41am, Tuesday, 29'th Mar 2022 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
Pfizer Announces Positive Results From Second Late-Stage Study Of Ulcerative Colitis Drug
Pfizer, Inc.
Lipocine GAAP EPS of -$0.01, revenue of $16.1M
02:08pm, Wednesday, 09'th Mar 2022 Seeking Alpha
Lipocine press release (LPCN): FY GAAP EPS of -$0.01.Revenue of $16.1M.As of December 31, 2021, the company had $44.6 million of unrestricted cash, cash equivalents, and…
Stock Of Lipocine Inc. (NASDAQ: LPCN) Jumped By 35.58 Percent Over The Past Month, Is There Room For Upside?
01:30pm, Friday, 04'th Mar 2022 Marketing Sentinel
Lipocine Inc. (NASDAQ:LPCN)’s traded shares stood at 1.31 million during the last session, with the company’s beta value hitting 0.22. At the close of trading, the stock’s price was $1.41, to imply an increase of 8.46% or $0.11 in intraday trading. The LPCN share’s 52-week high remains $2.03, putting it -43.97% down since that peak … Stock Of Lipocine Inc. (NASDAQ: LPCN) Jumped By 35.58 Percent Over The Past Month, Is There Room For Upside? Read More »
Attention Biotech Investors: Mark Your Calendar For March PDUFA Dates
12:08pm, Wednesday, 02'nd Mar 2022 Benzinga
The Food and Drug Administration approval calendar was light in February. Nevertheless, the month saw regulatory nods accorded to some breakthrough therapies.
Agios Pharmaceuticals, Inc.'s (NASDAQ: AG
Lipocine announces FDA accepted the marketing application for Tlando
02:34pm, Thursday, 03'rd Feb 2022 Seeking Alpha
Lipocine <> shares are trading higher after announcing that the FDA accepted the New Drug Application ("NDA") resubmission for Tlando (testosterone undecanoate), a potential rival
The Daily Biotech Pulse: Lilly Strikes Neurological R&D Collaboration, Valneva Confirms Vaccine Timelines, Biohaven Gains On Strong Migraine Drug Sales
01:24pm, Thursday, 06'th Jan 2022 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
Illumina Announces Co-Development Partnership With SomaScan For Accelerating Proteomics
Illumina, Inc.
Lipocine Inc. (NASDAQ: LPCN) Jumps 3.81%: Is This A Sign Of Things To Come?
04:00pm, Saturday, 18'th Dec 2021 Stocks Register
Lipocine Inc. (NASDAQ:LPCN) shares, rose in value on Friday, 12/17/21, with the stock price up by 3.81% to the previous days close as strong demand from buyers drove the stock to $1.09. Actively observing the price movement in the last trading, the stock closed the session at $1.05, falling within a range of $1.02 and Lipocine Inc. (NASDAQ: LPCN) Jumps 3.81%: Is This A Sign Of Things To Come? Read More »
Contrasting Sesen Bio (NASDAQ:SESN) & Lipocine (NASDAQ:LPCN)
11:24am, Tuesday, 07'th Dec 2021 Transcript Daily
Sesen Bio (NASDAQ:SESN) and Lipocine (NASDAQ:LPCN) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, valuation, dividends, analyst recommendations and risk. Profitability This table compares Sesen Bio and Lipocines net margins, return on equity and return on []